Skip to main content

Table 1 Characteristics of patients studied

From: Combined low initial DNA damage and high radiation-induced apoptosis confers clinical resistance to long-term toxicity in breast cancer patients treated with high-dose radiotherapy

 

N (%)

Mean ± SD

Median (Range)

Age

 

57.62 ± 12.9

60 (30-83)

   <60 years

12 (46.2)

  

   ≥60 years

14 (53.8)

  

Menopause

   

   Premenopausal

8 (30.8)

  

   Postmenopausal

18 (69.2)

  

Tumor type

   

   Inflammatory

7 (26.9)

  

   Non-inflammatory

19 (73.1)

  

Tumor size

   

   T3

1 (3.8)

  

   T4a-T4b

18 (69.2)

  

   T4c-T4d

7 (27.0)

  

Nodes

   

   N0

18 (69.2)

  

   N1-N2

8 (30.8)

  

Metastasis

   

   M0

24 (92.3)

  

   M1

2 (7.7)

  

Bra size

 

100 ± 10.6

100 (80-120)

   <100

9 (34.6)

  

   ≥100

17 (65.4)

  

Systemic treatment

   

   Chemotherapy

4 (15.4)

  

   Hormonal therapy

5 (19.2)

  

   Chemotherapy-hormonal therapy

17 (65.4)

  

Received dose (Gy)

 

78.48 ± 5.7

81.60 (64.8-81.6)

   <81.6

7 (26.9)

  

   ≥81.6

19 (73.1)

  

Maximum dose (Gy)

 

87.36 ± 8.8

89.76 (62.8-101.7)

   <89.8

15 (57.7)

  

   ≥89.8

11 (42.3)